Journal of Medicinal Chemistry · 2006 · 72 citations · 27 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologyStructure-activity RelationshipsCannabinoid PharmacologyDrug-receptor InteractionsHeterocyclic ChemistryLigand BindingStructure-activity Relationship AnalysisBiological Evaluation ReportCannabinoid AgonistsCannabinoid Receptor PharmacologyCannabinoid Structure-activity RelationshipsPyrazole ChemistryPyrazole Synthesis
New analogues (2a-p) of the previously reported CB(2) ligands 6-methyl- and 6-chloro-1-(2',4'-dichlorophenyl)-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamides (1a,b) have been synthesized and evaluated for cannabinoid receptor affinity. One example, 1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexyilamine-1,4-dihydroindeno[1,2-c] pyrazole-3-carboxamide (2a) was shown to have single digit nanomolar affinity for cannabinoid CB(2) receptors. Furthermore, compounds 2a and 2b, as well as lead structures 1a,b, were also shown to be agonist in an in vitro model based on human promyelocytic leukemia HL-60 cells.
27
Molecular characterization of a peripheral receptor for cannabinoids
Sean Munro, Kerrie L. Thomas, Muna Abu-Shaar · Nature · 1993 · 5.1K citations
Cannabinoid pharmacology: the first 66 years
Roger G. Pertwee · British Journal of Pharmacology · 2006 · 774 citations · Full text